Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
AstraZeneca
Atavistik Bio, Inc
Compass Therapeutics
PMV Pharmaceuticals, Inc
Mayo Clinic
Mayo Clinic
University of Michigan Rogel Cancer Center
Alterome Therapeutics, Inc.
Rutgers, The State University of New Jersey
Eli Lilly and Company
BeOne Medicines
Bayer
Psyence Australia Pty Ltd
Genmab
Jazz Pharmaceuticals
Rutgers, The State University of New Jersey
Kaiser Permanente
Children's Oncology Group
AstraZeneca
Duke University
AstraZeneca
Myeloid Therapeutics
Tizona Therapeutics, Inc
Mayo Clinic